Table 3.
Parameters | Control (Mean ± SE) | LC15 (Mean ± SE) | P value | Control (Mean ± SE) | LC30 (Mean ± SE) | P-value |
---|---|---|---|---|---|---|
r | 0.302 ± 0.0054a | 0.275 ± 0.0050b | 0.0002 | 0.302 ± 5.413a | 0.196 ± 0.0030b | <0.001 |
λ | 1.353 ± 0.0073a | 1.317 ± 0.0066b | 0.0002 | 1.353 ± 7.325a | 1.217 ± 0.0037b | <0.001 |
R0 | 35.166 ± 0.302a | 28.236 ± 0.820b | <0.001 | 35.166 ± 0.302a | 12.266 ± 0.256b | <0.001 |
T | 11.771 ± 0.217a | 12.125 ± 0.212a | 0.243 | 11.771 ± 0.217b | 12.741 ± 0.223a | 0.0019 |
GRR | 42.412 ± 0.923a | 40.529 ± 1.359a | 0.221 | 42.412 ± 0.923a | 21.137 ± 0.983b | <0.001 |
Different letters within the same row show significant differences between control and buprofezin concentration groups (at the P < 0.05 level, paired bootstrap test using TWOSEX MS chart program).